Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis Article Swipe
Jesica Martín Carmona
,
Diana Corona‐Mata
,
Francisco Téllez
,
Miguel Nicolás Navarrete Lorite
,
Isabel Barroso
,
Juan Carlos Alados
,
Rosario Palacios Muñoz
,
Ignacio de los Santos
,
Francisco Jesús Vera-Méndez
,
Arkaitz Imaz
,
Miguel Raffo Márquez
,
Aitana Carla Morano Vázquez
,
Marı́a José Galindo
,
Olga Belinchón
,
Miriam Serrano Fuentes
,
Miguel Ángel López Zúñiga
,
Carlos Galera Peñaranda
,
Sergio Reus
,
Juan A. Pineda
,
Juan Macı́as
,
Anaïs Corma‐Gómez
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1097/qad.0000000000004357
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1097/qad.0000000000004357
Objetive: This study analyses liver stiffness (LS) dynamics in people living with HIV (PLWH) and advanced liver fibrosis who achieved SVR and assess factors associated with LS normalization or progression, after long-term follow-up. Design: Prospective multicentre cohort study. Methods: this study included individuals with HIV/HCV co-infection from the Spanish GEHEP-011 cohort, fulfilling: 1) pre-treatment LS≥9.5kPa; 2) sustained virological response (SVR) with direct-acting antiviral regimen; 3) available measurement of LS at SVR. Factors associated with LS normalization (achieving ≤7.2kPa in two consecutive measurement) and progression (increase of >20% LS at the last measurement available) were analysed. Results: 678 patients were included. The median follow-up was 40 (17–71) months. The repeated measures ANOVA revealed a significant main effect of time on LS. Overall, 221 (32.6%) achieved normalization. Lower probability of normalization was associated with advanced liver disease [baseline LS: sHR = 0.26 (95% CI, 0.19–0.37), p < 0.001; liver decompensation before SVR: sHR = 0.22 (0.05–0.97), p < 0.001; baseline MELD score: sHR = 0.81 (0.69–0.94), p = 0.006]. LS progression occurred in 50 (7.4%). Progression was associated with higher baseline LS [sHR = 1.04 (1.01–1.07), p = 0.007], controlled attenuation parameter (CAP) [CAP≥280 dB/m: sHR = 2.94 (1.16–7.44)] and older age [sHR 1.06 (1.00–1.13), per year, p = 0.04]. Conclusions: In PLWH, LS significantly decreases after HCV cure in the long-term, achieving values of ≤7.2kPa. In a substantial proportion of patients, LS remain stable or even increases. Older age and concomitant steatotic liver disease are associated with LS progression.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/qad.0000000000004357
- OA Status
- hybrid
- OpenAlex ID
- https://openalex.org/W4414511310
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414511310Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/qad.0000000000004357Digital Object Identifier
- Title
-
Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-24Full publication date if available
- Authors
-
Jesica Martín Carmona, Diana Corona‐Mata, Francisco Téllez, Miguel Nicolás Navarrete Lorite, Isabel Barroso, Juan Carlos Alados, Rosario Palacios Muñoz, Ignacio de los Santos, Francisco Jesús Vera-Méndez, Arkaitz Imaz, Miguel Raffo Márquez, Aitana Carla Morano Vázquez, Marı́a José Galindo, Olga Belinchón, Miriam Serrano Fuentes, Miguel Ángel López Zúñiga, Carlos Galera Peñaranda, Sergio Reus, Juan A. Pineda, Juan Macı́as, Anaïs Corma‐GómezList of authors in order
- Landing page
-
https://doi.org/10.1097/qad.0000000000004357Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/qad.0000000000004357Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4414511310 |
|---|---|
| doi | https://doi.org/10.1097/qad.0000000000004357 |
| ids.doi | https://doi.org/10.1097/qad.0000000000004357 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40996506 |
| ids.openalex | https://openalex.org/W4414511310 |
| fwci | 0.0 |
| type | article |
| title | Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10351 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Liver Disease Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10151 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9998000264167786 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2721 |
| topics[1].subfield.display_name | Hepatology |
| topics[1].display_name | Hepatitis C virus research |
| topics[2].id | https://openalex.org/T10526 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9968000054359436 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | HIV/AIDS drug development and treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1097/qad.0000000000004357 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S20605092 |
| locations[0].source.issn | 0269-9370, 1473-5571 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0269-9370 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | AIDS |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | AIDS |
| locations[0].landing_page_url | https://doi.org/10.1097/qad.0000000000004357 |
| locations[1].id | pmid:40996506 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | AIDS (London, England) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40996506 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5029959226 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6791-4745 |
| authorships[0].author.display_name | Jesica Martín Carmona |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].raw_affiliation_string | Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com). |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210133602 |
| authorships[0].affiliations[1].raw_affiliation_string | Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Sevilla, Spain. |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I4210148397 |
| authorships[0].affiliations[2].raw_affiliation_string | Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain |
| authorships[0].affiliations[3].institution_ids | https://openalex.org/I79238269 |
| authorships[0].affiliations[3].raw_affiliation_string | Universidad de Sevilla (US), Sevilla, Spain |
| authorships[0].affiliations[4].institution_ids | https://openalex.org/I2801357902, https://openalex.org/I4210115082 |
| authorships[0].affiliations[4].raw_affiliation_string | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| authorships[0].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[0].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[0].institutions[1].id | https://openalex.org/I4210148397 |
| authorships[0].institutions[1].ror | https://ror.org/04cxs7048 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210148397 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Hospital Universitario de Valme |
| authorships[0].institutions[2].id | https://openalex.org/I4210133602 |
| authorships[0].institutions[2].ror | https://ror.org/031zwx660 |
| authorships[0].institutions[2].type | facility |
| authorships[0].institutions[2].lineage | https://openalex.org/I134820265, https://openalex.org/I158283456, https://openalex.org/I4210133602, https://openalex.org/I79238269, https://openalex.org/I918821925 |
| authorships[0].institutions[2].country_code | ES |
| authorships[0].institutions[2].display_name | Instituto de Biomedicina de Sevilla |
| authorships[0].institutions[3].id | https://openalex.org/I2801357902 |
| authorships[0].institutions[3].ror | https://ror.org/00ca2c886 |
| authorships[0].institutions[3].type | nonprofit |
| authorships[0].institutions[3].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[0].institutions[3].country_code | ES |
| authorships[0].institutions[3].display_name | Instituto de Salud Carlos III |
| authorships[0].institutions[4].id | https://openalex.org/I79238269 |
| authorships[0].institutions[4].ror | https://ror.org/03yxnpp24 |
| authorships[0].institutions[4].type | education |
| authorships[0].institutions[4].lineage | https://openalex.org/I79238269 |
| authorships[0].institutions[4].country_code | ES |
| authorships[0].institutions[4].display_name | Universidad de Sevilla |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jesica Martín-Carmona |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Sevilla, Spain., Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com)., Universidad de Sevilla (US), Sevilla, Spain |
| authorships[1].author.id | https://openalex.org/A5077861802 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8059-7171 |
| authorships[1].author.display_name | Diana Corona‐Mata |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210093628, https://openalex.org/I53110688 |
| authorships[1].affiliations[0].raw_affiliation_string | Infectious Diseases Unit, Maimonides Institute for Biomedical Research (IMIBIC), University Hospital Reina Sofía, University of Cordoba, Cordoba, Spain |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I2801357902, https://openalex.org/I4210115082 |
| authorships[1].affiliations[1].raw_affiliation_string | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| authorships[1].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[1].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[1].institutions[1].id | https://openalex.org/I4210093628 |
| authorships[1].institutions[1].ror | https://ror.org/00j9b6f88 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210093628 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | Instituto Maimónides de Investigación Biomédica de Córdoba |
| authorships[1].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[1].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[1].institutions[2].type | nonprofit |
| authorships[1].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[1].institutions[2].country_code | ES |
| authorships[1].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[1].institutions[3].id | https://openalex.org/I53110688 |
| authorships[1].institutions[3].ror | https://ror.org/05yc77b46 |
| authorships[1].institutions[3].type | education |
| authorships[1].institutions[3].lineage | https://openalex.org/I53110688 |
| authorships[1].institutions[3].country_code | ES |
| authorships[1].institutions[3].display_name | University of Córdoba |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Diana Corona-Mata |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Infectious Diseases Unit, Maimonides Institute for Biomedical Research (IMIBIC), University Hospital Reina Sofía, University of Cordoba, Cordoba, Spain |
| authorships[2].author.id | https://openalex.org/A5077472923 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9997-6761 |
| authorships[2].author.display_name | Francisco Téllez |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I39147953, https://openalex.org/I4210137875 |
| authorships[2].affiliations[0].raw_affiliation_string | Unit of Infectious Diseases, Hospital Universitario de Puerto Real, Cadiz, Spain. Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210137875 |
| authorships[2].institutions[0].ror | https://ror.org/04fbqvq73 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210137875 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Hospital Universitario Puerto Real |
| authorships[2].institutions[1].id | https://openalex.org/I39147953 |
| authorships[2].institutions[1].ror | https://ror.org/04mxxkb11 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I39147953 |
| authorships[2].institutions[1].country_code | ES |
| authorships[2].institutions[1].display_name | Universidad de Cádiz |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Francisco Téllez |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Unit of Infectious Diseases, Hospital Universitario de Puerto Real, Cadiz, Spain. Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain |
| authorships[3].author.id | https://openalex.org/A5045255040 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Miguel Nicolás Navarrete Lorite |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210090436 |
| authorships[3].affiliations[0].raw_affiliation_string | Unit of Infectious Diseases, Hospital Universitario Virgen Macarena, Sevilla, Spain. |
| authorships[3].institutions[0].id | https://openalex.org/I4210090436 |
| authorships[3].institutions[0].ror | https://ror.org/016p83279 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210090436 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Hospital Universitario Virgen Macarena |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Miguel Nicolás Navarrete Lorite |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Unit of Infectious Diseases, Hospital Universitario Virgen Macarena, Sevilla, Spain. |
| authorships[4].author.id | https://openalex.org/A5043815706 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5112-6015 |
| authorships[4].author.display_name | Isabel Barroso |
| authorships[4].affiliations[0].raw_affiliation_string | Unit of Clinical Microbiology, Hospital Universitario de Jerez, Cadiz, Spain |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Isabel Barroso |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Unit of Clinical Microbiology, Hospital Universitario de Jerez, Cadiz, Spain |
| authorships[5].author.id | https://openalex.org/A5003526968 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5361-3968 |
| authorships[5].author.display_name | Juan Carlos Alados |
| authorships[5].affiliations[0].raw_affiliation_string | Unit of Clinical Microbiology, Hospital Universitario de Jerez, Cadiz, Spain |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Juan Carlos Alados |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Unit of Clinical Microbiology, Hospital Universitario de Jerez, Cadiz, Spain |
| authorships[6].author.id | https://openalex.org/A5110611521 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Rosario Palacios Muñoz |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210157481, https://openalex.org/I4210164724 |
| authorships[6].affiliations[0].raw_affiliation_string | Unit of Infectious Diseases and Microbiology, Hospital Virgen de la Victoria, Málaga, Spain. IBIMA, Málaga, Spain. |
| authorships[6].institutions[0].id | https://openalex.org/I4210157481 |
| authorships[6].institutions[0].ror | https://ror.org/05xxs2z38 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210157481 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Hospital Clínico Universitario Virgen de la Victoria |
| authorships[6].institutions[1].id | https://openalex.org/I4210164724 |
| authorships[6].institutions[1].ror | https://ror.org/05n3asa33 |
| authorships[6].institutions[1].type | facility |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210164724 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Instituto de Investigación Biomédica de Málaga |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Rosario Palacios Muñoz |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Unit of Infectious Diseases and Microbiology, Hospital Virgen de la Victoria, Málaga, Spain. IBIMA, Málaga, Spain. |
| authorships[7].author.id | https://openalex.org/A5028478010 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-7073-5211 |
| authorships[7].author.display_name | Ignacio de los Santos |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210130498 |
| authorships[7].affiliations[0].raw_affiliation_string | Unit of Internal Medicine and Infectious Diseases, Hospital La Princesa, Madrid, Spain |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I2801357902, https://openalex.org/I4210115082 |
| authorships[7].affiliations[1].raw_affiliation_string | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| authorships[7].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[7].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[7].institutions[1].id | https://openalex.org/I4210130498 |
| authorships[7].institutions[1].ror | https://ror.org/03cg5md32 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210130498, https://openalex.org/I4210139293 |
| authorships[7].institutions[1].country_code | ES |
| authorships[7].institutions[1].display_name | Hospital Universitario de La Princesa |
| authorships[7].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[7].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[7].institutions[2].type | nonprofit |
| authorships[7].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[7].institutions[2].country_code | ES |
| authorships[7].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ignacio de Los Santos |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Unit of Internal Medicine and Infectious Diseases, Hospital La Princesa, Madrid, Spain |
| authorships[8].author.id | https://openalex.org/A5048817078 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Francisco Jesús Vera-Méndez |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210146010 |
| authorships[8].affiliations[0].raw_affiliation_string | Section of Infectious Medicine/Service of Internal Medicine, Hospital General Universitario Santa Lucía, Cartagena, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210146010 |
| authorships[8].institutions[0].ror | https://ror.org/051fvq837 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210146010 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Santa Lucía University General Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Francisco Jesús Vera-Méndez |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Section of Infectious Medicine/Service of Internal Medicine, Hospital General Universitario Santa Lucía, Cartagena, Spain |
| authorships[9].author.id | https://openalex.org/A5043509211 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8411-1952 |
| authorships[9].author.display_name | Arkaitz Imaz |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[9].affiliations[0].raw_affiliation_string | HIV and STI Unit, Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain |
| authorships[9].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[9].institutions[0].ror | https://ror.org/00epner96 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Bellvitge University Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Arkaitz Imaz |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | HIV and STI Unit, Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain |
| authorships[10].author.id | https://openalex.org/A5059591451 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Miguel Raffo Márquez |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210129320 |
| authorships[10].affiliations[0].raw_affiliation_string | Unit of Infectious Diseases, Hospital Universitario Juan Ramón Jimenez, Huelva, Spain |
| authorships[10].institutions[0].id | https://openalex.org/I4210129320 |
| authorships[10].institutions[0].ror | https://ror.org/03fpqn433 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210129320 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Hospital Juan Ramón Jiménez |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Miguel Raffo Márquez |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Unit of Infectious Diseases, Hospital Universitario Juan Ramón Jimenez, Huelva, Spain |
| authorships[11].author.id | https://openalex.org/A5102004870 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2222-1002 |
| authorships[11].author.display_name | Aitana Carla Morano Vázquez |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2802353815 |
| authorships[11].affiliations[0].raw_affiliation_string | Unit of Infectious Diseases, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain. Instituto de Investigación Sanitaria Galicia Sur (IISGS), Spain |
| authorships[11].institutions[0].id | https://openalex.org/I2802353815 |
| authorships[11].institutions[0].ror | https://ror.org/01ybfxd46 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I2802353815, https://openalex.org/I4210158352 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | University Hospital Complex Of Vigo |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Aitana Carla Morano Vázquez |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Unit of Infectious Diseases, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain. Instituto de Investigación Sanitaria Galicia Sur (IISGS), Spain |
| authorships[12].author.id | https://openalex.org/A5110216254 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Marı́a José Galindo |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210158373 |
| authorships[12].affiliations[0].raw_affiliation_string | INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I4210094406 |
| authorships[12].affiliations[1].raw_affiliation_string | Unit of Internal Medicine – Infectious Diseases, Hospital Universitario Clínico-Malvarrosa, Valencia, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I4210094406 |
| authorships[12].institutions[0].ror | https://ror.org/00hpnj894 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210094406 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Hospital Clínico Universitario de Valencia |
| authorships[12].institutions[1].id | https://openalex.org/I4210158373 |
| authorships[12].institutions[1].ror | https://ror.org/059wbyv33 |
| authorships[12].institutions[1].type | healthcare |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210158373 |
| authorships[12].institutions[1].country_code | ES |
| authorships[12].institutions[1].display_name | INCLIVA Health Research Institute |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | María José Galindo |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain, Unit of Internal Medicine – Infectious Diseases, Hospital Universitario Clínico-Malvarrosa, Valencia, Spain |
| authorships[13].author.id | https://openalex.org/A5009297777 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Olga Belinchón |
| authorships[13].countries | ES |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210092665 |
| authorships[13].affiliations[0].raw_affiliation_string | Unit of Internal Medicine, Hospital General Virgen de la Luz, Cuenca, Spain |
| authorships[13].institutions[0].id | https://openalex.org/I4210092665 |
| authorships[13].institutions[0].ror | https://ror.org/00k49k182 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210092665, https://openalex.org/I4210141158 |
| authorships[13].institutions[0].country_code | ES |
| authorships[13].institutions[0].display_name | Hospital Virgen de la Luz |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Olga Belinchón |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Unit of Internal Medicine, Hospital General Virgen de la Luz, Cuenca, Spain |
| authorships[14].author.id | https://openalex.org/A5066481865 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Miriam Serrano Fuentes |
| authorships[14].countries | ES |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210098027 |
| authorships[14].affiliations[0].raw_affiliation_string | Unit of Internal Medicine, Liver Disease Clinic, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain |
| authorships[14].institutions[0].id | https://openalex.org/I4210098027 |
| authorships[14].institutions[0].ror | https://ror.org/00s4vhs88 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210098027 |
| authorships[14].institutions[0].country_code | ES |
| authorships[14].institutions[0].display_name | Hospital Universitario de Gran Canaria Doctor Negrín |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Miriam Serrano Fuentes |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Unit of Internal Medicine, Liver Disease Clinic, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain |
| authorships[15].author.id | https://openalex.org/A5063279255 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-2583-316X |
| authorships[15].author.display_name | Miguel Ángel López Zúñiga |
| authorships[15].countries | ES |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210113665, https://openalex.org/I4210116170 |
| authorships[15].affiliations[0].raw_affiliation_string | Infectious Disease Unit, Internal Medicine Service, Hospital Universitario Virgen de las Nieves, Granada, Spain. Instituto de Investigación Biosanitaria de Granada (IIBG), Granada, Spain |
| authorships[15].institutions[0].id | https://openalex.org/I4210116170 |
| authorships[15].institutions[0].ror | https://ror.org/02f01mz90 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210116170 |
| authorships[15].institutions[0].country_code | ES |
| authorships[15].institutions[0].display_name | Hospital Universitario Virgen de las Nieves |
| authorships[15].institutions[1].id | https://openalex.org/I4210113665 |
| authorships[15].institutions[1].ror | https://ror.org/026yy9j15 |
| authorships[15].institutions[1].type | facility |
| authorships[15].institutions[1].lineage | https://openalex.org/I4210113665 |
| authorships[15].institutions[1].country_code | ES |
| authorships[15].institutions[1].display_name | Instituto de Investigación Biosanitaria de Granada |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Miguel Ángel López Zúñiga |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Infectious Disease Unit, Internal Medicine Service, Hospital Universitario Virgen de las Nieves, Granada, Spain. Instituto de Investigación Biosanitaria de Granada (IIBG), Granada, Spain |
| authorships[16].author.id | https://openalex.org/A5015400806 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Carlos Galera Peñaranda |
| authorships[16].countries | ES |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210150677 |
| authorships[16].affiliations[0].raw_affiliation_string | UNITS. Unit of Internal Medicine, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain. IMIB Pascual Parrilla, Murcia, Spain |
| authorships[16].institutions[0].id | https://openalex.org/I4210150677 |
| authorships[16].institutions[0].ror | https://ror.org/058thx797 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210150677 |
| authorships[16].institutions[0].country_code | ES |
| authorships[16].institutions[0].display_name | Hospital Universitario Virgen de la Arrixaca |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Carlos Galera Peñaranda |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | UNITS. Unit of Internal Medicine, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain. IMIB Pascual Parrilla, Murcia, Spain |
| authorships[17].author.id | https://openalex.org/A5042658460 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-3320-9754 |
| authorships[17].author.display_name | Sergio Reus |
| authorships[17].countries | ES |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210137674 |
| authorships[17].affiliations[0].raw_affiliation_string | Hospital General Universitario Dr Balmis de Alicante, Spain. ISABIAL, Alicante, Spain. |
| authorships[17].institutions[0].id | https://openalex.org/I4210137674 |
| authorships[17].institutions[0].ror | https://ror.org/02ybsz607 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210137674 |
| authorships[17].institutions[0].country_code | ES |
| authorships[17].institutions[0].display_name | Hospital General Universitario de Alicante Doctor Balmis |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Sergio Javier Reus-Bañuls |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Hospital General Universitario Dr Balmis de Alicante, Spain. ISABIAL, Alicante, Spain. |
| authorships[18].author.id | https://openalex.org/A5070949389 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-3751-0296 |
| authorships[18].author.display_name | Juan A. Pineda |
| authorships[18].countries | ES, US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I79238269 |
| authorships[18].affiliations[0].raw_affiliation_string | Universidad de Sevilla (US), Sevilla, Spain |
| authorships[18].affiliations[1].institution_ids | https://openalex.org/I188703185 |
| authorships[18].affiliations[1].raw_affiliation_string | fax: +34955015795 |
| authorships[18].affiliations[2].institution_ids | https://openalex.org/I4210148397 |
| authorships[18].affiliations[2].raw_affiliation_string | Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain |
| authorships[18].institutions[0].id | https://openalex.org/I4210148397 |
| authorships[18].institutions[0].ror | https://ror.org/04cxs7048 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210148397 |
| authorships[18].institutions[0].country_code | ES |
| authorships[18].institutions[0].display_name | Hospital Universitario de Valme |
| authorships[18].institutions[1].id | https://openalex.org/I79238269 |
| authorships[18].institutions[1].ror | https://ror.org/03yxnpp24 |
| authorships[18].institutions[1].type | education |
| authorships[18].institutions[1].lineage | https://openalex.org/I79238269 |
| authorships[18].institutions[1].country_code | ES |
| authorships[18].institutions[1].display_name | Universidad de Sevilla |
| authorships[18].institutions[2].id | https://openalex.org/I188703185 |
| authorships[18].institutions[2].ror | https://ror.org/0400j3f74 |
| authorships[18].institutions[2].type | company |
| authorships[18].institutions[2].lineage | https://openalex.org/I188703185 |
| authorships[18].institutions[2].country_code | US |
| authorships[18].institutions[2].display_name | GTx (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Juan A. Pineda |
| authorships[18].is_corresponding | True |
| authorships[18].raw_affiliation_strings | Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain, Universidad de Sevilla (US), Sevilla, Spain, fax: +34955015795 |
| authorships[19].author.id | https://openalex.org/A5013551077 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-4778-790X |
| authorships[19].author.display_name | Juan Macı́as |
| authorships[19].countries | ES |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210133602 |
| authorships[19].affiliations[0].raw_affiliation_string | Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Sevilla, Spain. |
| authorships[19].affiliations[1].institution_ids | https://openalex.org/I4210148397 |
| authorships[19].affiliations[1].raw_affiliation_string | Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain |
| authorships[19].affiliations[2].institution_ids | https://openalex.org/I2801357902, https://openalex.org/I4210115082 |
| authorships[19].affiliations[2].raw_affiliation_string | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| authorships[19].affiliations[3].raw_affiliation_string | Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com). |
| authorships[19].affiliations[4].institution_ids | https://openalex.org/I79238269 |
| authorships[19].affiliations[4].raw_affiliation_string | Universidad de Sevilla (US), Sevilla, Spain |
| authorships[19].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[19].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[19].institutions[0].type | facility |
| authorships[19].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[19].institutions[0].country_code | ES |
| authorships[19].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[19].institutions[1].id | https://openalex.org/I4210148397 |
| authorships[19].institutions[1].ror | https://ror.org/04cxs7048 |
| authorships[19].institutions[1].type | healthcare |
| authorships[19].institutions[1].lineage | https://openalex.org/I4210148397 |
| authorships[19].institutions[1].country_code | ES |
| authorships[19].institutions[1].display_name | Hospital Universitario de Valme |
| authorships[19].institutions[2].id | https://openalex.org/I4210133602 |
| authorships[19].institutions[2].ror | https://ror.org/031zwx660 |
| authorships[19].institutions[2].type | facility |
| authorships[19].institutions[2].lineage | https://openalex.org/I134820265, https://openalex.org/I158283456, https://openalex.org/I4210133602, https://openalex.org/I79238269, https://openalex.org/I918821925 |
| authorships[19].institutions[2].country_code | ES |
| authorships[19].institutions[2].display_name | Instituto de Biomedicina de Sevilla |
| authorships[19].institutions[3].id | https://openalex.org/I2801357902 |
| authorships[19].institutions[3].ror | https://ror.org/00ca2c886 |
| authorships[19].institutions[3].type | nonprofit |
| authorships[19].institutions[3].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[19].institutions[3].country_code | ES |
| authorships[19].institutions[3].display_name | Instituto de Salud Carlos III |
| authorships[19].institutions[4].id | https://openalex.org/I79238269 |
| authorships[19].institutions[4].ror | https://ror.org/03yxnpp24 |
| authorships[19].institutions[4].type | education |
| authorships[19].institutions[4].lineage | https://openalex.org/I79238269 |
| authorships[19].institutions[4].country_code | ES |
| authorships[19].institutions[4].display_name | Universidad de Sevilla |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Juan Macías |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Sevilla, Spain., Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com)., Universidad de Sevilla (US), Sevilla, Spain |
| authorships[20].author.id | https://openalex.org/A5081180287 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-1078-0237 |
| authorships[20].author.display_name | Anaïs Corma‐Gómez |
| authorships[20].countries | ES |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210158373 |
| authorships[20].affiliations[0].raw_affiliation_string | INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain |
| authorships[20].affiliations[1].raw_affiliation_string | Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com). |
| authorships[20].affiliations[2].institution_ids | https://openalex.org/I4210094406 |
| authorships[20].affiliations[2].raw_affiliation_string | Unit of Internal Medicine – Infectious Diseases, Hospital Universitario Clínico-Malvarrosa, Valencia, Spain |
| authorships[20].affiliations[3].institution_ids | https://openalex.org/I4210148397 |
| authorships[20].affiliations[3].raw_affiliation_string | Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain |
| authorships[20].affiliations[4].institution_ids | https://openalex.org/I2801357902, https://openalex.org/I4210115082 |
| authorships[20].affiliations[4].raw_affiliation_string | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
| authorships[20].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[20].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[20].institutions[0].type | facility |
| authorships[20].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[20].institutions[0].country_code | ES |
| authorships[20].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[20].institutions[1].id | https://openalex.org/I4210094406 |
| authorships[20].institutions[1].ror | https://ror.org/00hpnj894 |
| authorships[20].institutions[1].type | healthcare |
| authorships[20].institutions[1].lineage | https://openalex.org/I4210094406 |
| authorships[20].institutions[1].country_code | ES |
| authorships[20].institutions[1].display_name | Hospital Clínico Universitario de Valencia |
| authorships[20].institutions[2].id | https://openalex.org/I4210148397 |
| authorships[20].institutions[2].ror | https://ror.org/04cxs7048 |
| authorships[20].institutions[2].type | healthcare |
| authorships[20].institutions[2].lineage | https://openalex.org/I4210148397 |
| authorships[20].institutions[2].country_code | ES |
| authorships[20].institutions[2].display_name | Hospital Universitario de Valme |
| authorships[20].institutions[3].id | https://openalex.org/I4210158373 |
| authorships[20].institutions[3].ror | https://ror.org/059wbyv33 |
| authorships[20].institutions[3].type | healthcare |
| authorships[20].institutions[3].lineage | https://openalex.org/I4210158373 |
| authorships[20].institutions[3].country_code | ES |
| authorships[20].institutions[3].display_name | INCLIVA Health Research Institute |
| authorships[20].institutions[4].id | https://openalex.org/I2801357902 |
| authorships[20].institutions[4].ror | https://ror.org/00ca2c886 |
| authorships[20].institutions[4].type | nonprofit |
| authorships[20].institutions[4].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[20].institutions[4].country_code | ES |
| authorships[20].institutions[4].display_name | Instituto de Salud Carlos III |
| authorships[20].author_position | last |
| authorships[20].raw_author_name | Anaïs Corma-Gómez |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Sevilla, Spain, INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain, Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com)., Unit of Internal Medicine – Infectious Diseases, Hospital Universitario Clínico-Malvarrosa, Valencia, Spain |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/qad.0000000000004357 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10351 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Liver Disease Diagnosis and Treatment |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1097/qad.0000000000004357 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S20605092 |
| best_oa_location.source.issn | 0269-9370, 1473-5571 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0269-9370 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | AIDS |
| best_oa_location.source.host_organization | https://openalex.org/P4310315671 |
| best_oa_location.source.host_organization_name | Lippincott Williams & Wilkins |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | AIDS |
| best_oa_location.landing_page_url | https://doi.org/10.1097/qad.0000000000004357 |
| primary_location.id | doi:10.1097/qad.0000000000004357 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S20605092 |
| primary_location.source.issn | 0269-9370, 1473-5571 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0269-9370 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | AIDS |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | AIDS |
| primary_location.landing_page_url | https://doi.org/10.1097/qad.0000000000004357 |
| publication_date | 2025-09-24 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 138, 151, 161, 165, 181, 185, 194, 206 |
| abstract_inverted_index.a | 112, 225 |
| abstract_inverted_index.p | 143, 154, 164, 184, 205 |
| abstract_inverted_index.1) | 52 |
| abstract_inverted_index.2) | 55 |
| abstract_inverted_index.3) | 64 |
| abstract_inverted_index.40 | 104 |
| abstract_inverted_index.50 | 171 |
| abstract_inverted_index.In | 209, 224 |
| abstract_inverted_index.LS | 26, 68, 74, 87, 167, 179, 211, 230, 246 |
| abstract_inverted_index.at | 69, 88 |
| abstract_inverted_index.in | 8, 78, 170, 217 |
| abstract_inverted_index.of | 67, 85, 116, 127, 222, 228 |
| abstract_inverted_index.on | 118 |
| abstract_inverted_index.or | 28, 233 |
| abstract_inverted_index.221 | 121 |
| abstract_inverted_index.678 | 96 |
| abstract_inverted_index.CI, | 141 |
| abstract_inverted_index.HCV | 215 |
| abstract_inverted_index.HIV | 12 |
| abstract_inverted_index.LS. | 119 |
| abstract_inverted_index.LS: | 136 |
| abstract_inverted_index.SVR | 20 |
| abstract_inverted_index.The | 100, 107 |
| abstract_inverted_index.age | 199, 237 |
| abstract_inverted_index.and | 14, 21, 82, 197, 238 |
| abstract_inverted_index.are | 243 |
| abstract_inverted_index.per | 203 |
| abstract_inverted_index.sHR | 137, 150, 160, 193 |
| abstract_inverted_index.the | 47, 89, 218 |
| abstract_inverted_index.two | 79 |
| abstract_inverted_index.was | 103, 129, 174 |
| abstract_inverted_index.who | 18 |
| abstract_inverted_index.< | 144, 155 |
| abstract_inverted_index.(95% | 140 |
| abstract_inverted_index.(LS) | 6 |
| abstract_inverted_index.0.22 | 152 |
| abstract_inverted_index.0.26 | 139 |
| abstract_inverted_index.0.81 | 162 |
| abstract_inverted_index.1.04 | 182 |
| abstract_inverted_index.1.06 | 201 |
| abstract_inverted_index.2.94 | 195 |
| abstract_inverted_index.MELD | 158 |
| abstract_inverted_index.SVR. | 70 |
| abstract_inverted_index.SVR: | 149 |
| abstract_inverted_index.This | 1 |
| abstract_inverted_index.[sHR | 180, 200 |
| abstract_inverted_index.cure | 216 |
| abstract_inverted_index.even | 234 |
| abstract_inverted_index.from | 46 |
| abstract_inverted_index.last | 90 |
| abstract_inverted_index.main | 114 |
| abstract_inverted_index.this | 39 |
| abstract_inverted_index.time | 117 |
| abstract_inverted_index.were | 93, 98 |
| abstract_inverted_index.with | 11, 25, 43, 60, 73, 131, 176, 245 |
| abstract_inverted_index.(CAP) | 190 |
| abstract_inverted_index.(SVR) | 59 |
| abstract_inverted_index.ANOVA | 110 |
| abstract_inverted_index.Lower | 125 |
| abstract_inverted_index.Older | 236 |
| abstract_inverted_index.PLWH, | 210 |
| abstract_inverted_index.after | 30, 214 |
| abstract_inverted_index.dB/m: | 192 |
| abstract_inverted_index.liver | 4, 16, 133, 146, 241 |
| abstract_inverted_index.older | 198 |
| abstract_inverted_index.study | 2, 40 |
| abstract_inverted_index.year, | 204 |
| abstract_inverted_index.(PLWH) | 13 |
| abstract_inverted_index.0.001; | 145, 156 |
| abstract_inverted_index.0.04]. | 207 |
| abstract_inverted_index.assess | 22 |
| abstract_inverted_index.before | 148 |
| abstract_inverted_index.cohort | 36 |
| abstract_inverted_index.effect | 115 |
| abstract_inverted_index.higher | 177 |
| abstract_inverted_index.living | 10 |
| abstract_inverted_index.median | 101 |
| abstract_inverted_index.people | 9 |
| abstract_inverted_index.remain | 231 |
| abstract_inverted_index.score: | 159 |
| abstract_inverted_index.stable | 232 |
| abstract_inverted_index.study. | 37 |
| abstract_inverted_index.values | 221 |
| abstract_inverted_index.>20% | 86 |
| abstract_inverted_index.(32.6%) | 122 |
| abstract_inverted_index.(7.4%). | 172 |
| abstract_inverted_index.0.006]. | 166 |
| abstract_inverted_index.0.007], | 186 |
| abstract_inverted_index.Design: | 33 |
| abstract_inverted_index.Factors | 71 |
| abstract_inverted_index.HIV/HCV | 44 |
| abstract_inverted_index.Spanish | 48 |
| abstract_inverted_index.cohort, | 50 |
| abstract_inverted_index.disease | 134, 242 |
| abstract_inverted_index.factors | 23 |
| abstract_inverted_index.months. | 106 |
| abstract_inverted_index.Methods: | 38 |
| abstract_inverted_index.Overall, | 120 |
| abstract_inverted_index.Results: | 95 |
| abstract_inverted_index.achieved | 19, 123 |
| abstract_inverted_index.advanced | 15, 132 |
| abstract_inverted_index.analyses | 3 |
| abstract_inverted_index.baseline | 157, 178 |
| abstract_inverted_index.dynamics | 7 |
| abstract_inverted_index.fibrosis | 17 |
| abstract_inverted_index.included | 41 |
| abstract_inverted_index.measures | 109 |
| abstract_inverted_index.occurred | 169 |
| abstract_inverted_index.patients | 97 |
| abstract_inverted_index.regimen; | 63 |
| abstract_inverted_index.repeated | 108 |
| abstract_inverted_index.response | 58 |
| abstract_inverted_index.revealed | 111 |
| abstract_inverted_index.(17–71) | 105 |
| abstract_inverted_index.(increase | 84 |
| abstract_inverted_index.GEHEP-011 | 49 |
| abstract_inverted_index.Objetive: | 0 |
| abstract_inverted_index.[baseline | 135 |
| abstract_inverted_index.achieving | 220 |
| abstract_inverted_index.analysed. | 94 |
| abstract_inverted_index.antiviral | 62 |
| abstract_inverted_index.available | 65 |
| abstract_inverted_index.decreases | 213 |
| abstract_inverted_index.follow-up | 102 |
| abstract_inverted_index.included. | 99 |
| abstract_inverted_index.long-term | 31 |
| abstract_inverted_index.parameter | 189 |
| abstract_inverted_index.patients, | 229 |
| abstract_inverted_index.steatotic | 240 |
| abstract_inverted_index.stiffness | 5 |
| abstract_inverted_index.sustained | 56 |
| abstract_inverted_index.≤7.2kPa | 77 |
| abstract_inverted_index.(achieving | 76 |
| abstract_inverted_index.[CAP≥280 | 191 |
| abstract_inverted_index.associated | 24, 72, 130, 175, 244 |
| abstract_inverted_index.available) | 92 |
| abstract_inverted_index.controlled | 187 |
| abstract_inverted_index.follow-up. | 32 |
| abstract_inverted_index.increases. | 235 |
| abstract_inverted_index.long-term, | 219 |
| abstract_inverted_index.proportion | 227 |
| abstract_inverted_index.≤7.2kPa. | 223 |
| abstract_inverted_index.Progression | 173 |
| abstract_inverted_index.Prospective | 34 |
| abstract_inverted_index.attenuation | 188 |
| abstract_inverted_index.concomitant | 239 |
| abstract_inverted_index.consecutive | 80 |
| abstract_inverted_index.fulfilling: | 51 |
| abstract_inverted_index.individuals | 42 |
| abstract_inverted_index.measurement | 66, 91 |
| abstract_inverted_index.multicentre | 35 |
| abstract_inverted_index.probability | 126 |
| abstract_inverted_index.progression | 83, 168 |
| abstract_inverted_index.significant | 113 |
| abstract_inverted_index.substantial | 226 |
| abstract_inverted_index.virological | 57 |
| abstract_inverted_index.Conclusions: | 208 |
| abstract_inverted_index.LS≥9.5kPa; | 54 |
| abstract_inverted_index.co-infection | 45 |
| abstract_inverted_index.measurement) | 81 |
| abstract_inverted_index.progression, | 29 |
| abstract_inverted_index.progression. | 247 |
| abstract_inverted_index.0.19–0.37), | 142 |
| abstract_inverted_index.direct-acting | 61 |
| abstract_inverted_index.normalization | 27, 75, 128 |
| abstract_inverted_index.pre-treatment | 53 |
| abstract_inverted_index.significantly | 212 |
| abstract_inverted_index.(0.05–0.97), | 153 |
| abstract_inverted_index.(0.69–0.94), | 163 |
| abstract_inverted_index.(1.00–1.13), | 202 |
| abstract_inverted_index.(1.01–1.07), | 183 |
| abstract_inverted_index.(1.16–7.44)] | 196 |
| abstract_inverted_index.decompensation | 147 |
| abstract_inverted_index.normalization. | 124 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5070949389 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 21 |
| corresponding_institution_ids | https://openalex.org/I188703185, https://openalex.org/I4210148397, https://openalex.org/I79238269 |
| citation_normalized_percentile.value | 0.5664423 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |